PMID: 16532722Mar 15, 2006Paper

New antithrombotic drugs in cardiovascular disease

Giornale italiano di cardiologia : organo ufficiale della Federazione italiana di cardiologia : organo ufficiale della Società italiana di chirurgia cardiaca
Paolo GolinoRaffaele Calabrò

Abstract

During the past decades, a great bulk of studies have been undertaken to investigate the pathophysiologic mechanisms responsible for thrombus formation. As a consequence, different therapeutic strategies interfering at different levels of the coagulation process have been developed. Many of these compounds did not achieve full development, but others are presently available for the clinician. The present review paper will focus on these new therapeutic strategies developed in the last 10 years.

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Advances in Pharmacology
P Thiagarajan, K K Wu
Recenti progressi in medicina
M R Taliani, G Agnelli
British Medical Journal
B T Marsh, K Lambaa
Treatment Guidelines From the Medical Letter
The Medical Letter on Drugs and Therapeutics
© 2021 Meta ULC. All rights reserved